RE: sp hit 14 p recemtly before MTA's RNS ..now we cant even breach 10p...go figure figure9 Jun 2021 17:42
@star786. Inspired by your comment that N4P gives regular and timely updates, I tracked back to an earlier post of mine from about a month ago. I listed the meaningful RNSs by month over the previous year, and then made a remarkably prescient comment:
"May 2020 = 3. Placing/Broker, Patent Filing, Covid update
June = 0
July = 1. Work Programme & Strategic Update
Aug = 1. Positive Covid In-Vitro Study
Sept = 3. Tech Transfer & M'fact, Covid PoC Update, Interim Results
Oct = 0
Nov = 2. Operational Update, Nuvec/Oncology launch
Dec = 2. Formulation work update, £2M Placing
2021
Jan = 0
Feb = 2. Intention to Grant Patent, Final Results
Mar = 0
Apr = 0
May = 0
It's been a long silence recently and work - we must assume - is continuing behind the scenes. My post isn't intended to criticise, just to point out that something's increasingly likely to land soon. As a reminder of what may come in the next few months:
Oncology - Stage 2 of the programme expected to conclude in Autumn (up to 12 months from Nov 2020)
Nuvec in-vivo - due to commence early in 2021 (did I miss announcement of it starting ?)
Patent - full grant should take 6-8 months (started in Feb, so due in early autumn)
Nanomerics - 14 month research collaboration started Feb 2020 (so expired April 2021 ???). Announcement could be imminent on renewing Nanomerics agreement, or new research partner
But for me the prime suspect for news would be the collaboration discussions with potential licensing partners."
A week later we get announcement of the MTAs.
So, yes, N4 does provide updates generally but there'd been a VERY long gap this spring. Which makes me think there are likely to be a sequence of them in the next 3-5 months which will take the company forward significantly. I hope.